HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

Market Cap	5.05B +6.1%
Revenue (ttm)	10.64B +4.1%
Net Income	158.58M +33.1%
EPS	0.27 +33.1%
Shares Out	579.89M
PE Ratio	31.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,730,987
Open	8.47
Previous Close	8.61
Day's Range	8.21 - 8.73
52-Week Range	7.54 - 18.13
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 20, 2026

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers chemical drugs, traditional Chinese medicine, biological products, and medical supplies; medical instruments, traditional Chinese medicine decoction pieces, health foods, daily necessities, glassware, and chemical reagents, etc.; It serves its products through e-commerce platforms, direct sales, and a chain of direct stores and online B2C, O2O, etc. The company was founded in 1950 and is h...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1950
• Employees: 2,735
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600829

Financial Performance

In 2025, SHA:600829's revenue was 10.38 billion, an increase of 3.29% compared to the previous year's 10.05 billion. Earnings were 133.84 million, a decrease of -37.24%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error